Clinical Trial Update: Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Chronic Hepatitis C Participants With Child-Pugh (CP)-B Hepatic Insufficiency (MK-5172-059) [Phase 2, Phase 3]

View source ↗

Summary

Study evaluating the efficacy and safety of grazoprevir and elbasvir in chronic hepatitis C patients with Child-Pugh B hepatic insufficiency has completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Elbasvir (elbasvir)
• Grazoprevir (grazoprevir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Hepatitis C | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-03-17